Results 151 to 160 of about 224,448 (162)

Similarity of dissolution profiles from biorelevant media: Assessment of interday repeatability, interanalyst repeatability, and interlaboratory reproducibility using ibuprofen and ketoconazole tablets

European Journal of Pharmaceutical Sciences, 2021
Harsh Shah, James E Polli, Kajal Nahar
exaly  

Sources of dissolution variability into biorelevant media

International Journal of Pharmaceutics, 2022
James E Polli
exaly  

A new biorelevant dissolution method for orodispersible films

European Journal of Pharmaceutics and Biopharmaceutics, 2016
Joerg Breitkreutz, Miriam Pein-Hackelbusch   +1 more
exaly  

Characterising the behaviour of poorly water soluble drugs in the intestine: application of biorelevant media for solubility, dissolution and transport studies.

Journal of Pharmacy and Pharmacology, 2010
Jette Bredahl Jacobsen, Anette Müllertz, Karen Kleberg   +2 more
exaly  

Establishing virtual bioequivalence and clinically relevant specifications using biorelevant dissolution testing and physiologically-based population pharmacokinetic modeling. case example: Naproxen

European Journal of Pharmaceutical Sciences, 2020
Jennifer Dressman, Nikoletta Fotaki, Ioannis Loisios-Konstantinidis   +2 more
exaly  

Biorelevant dissolution media as a predictive tool for glyburide a class II drug

European Journal of Pharmaceutical Sciences, 2006
Raimar Löbenberg
exaly  

Application of biorelevant dissolution tests to the prediction of performance of diclofenac sodium from an oral modified-release pellet dosage form

European Journal of Pharmaceutical Sciences, 2009
Jennifer Dressman, Maria Vertzoni, Ekarat Jantratid   +2 more
exaly  

Biorelevant dissolution testing of products containing micronized or nanosized fenofibrate with a view to predicting plasma profiles

European Journal of Pharmaceutics and Biopharmaceutics, 2011
Jennifer Dressman, Christos Reppas, Maria Vertzoni   +2 more
exaly  

Investigation of dissolution behavior of diclofenac sodium extended release formulations under standard and biorelevant test conditions

Drug Development and Industrial Pharmacy, 2010
Werner Weitschies, Grzegorz Garbacz
exaly  

Development and Application of a Biorelevant Dissolution Method Using USP Apparatus 4 in Early Phase Formulation Development

Molecular Pharmaceutics, 2010
Tawnya G Flick
exaly